We are live on ! Find out more
MRDB.WS

MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share
MRDB.WS

Delisted

MRDB.WS was delisted on the 23rd of August, 2024.

24 hedge funds and large institutions have $4.6M invested in MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+24
Holders Change %
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
Reduced
Closed
Calls
$679K
Puts
Net Calls
+$679K
Net Calls Change
+$679K

MRDB.WS Hedge Fund Activity: Q4 2022 in Review

24 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share (MRDB.WS) for Q4 2022, worth a combined $4.6M.

Buyers outnumbered sellers: 24 funds opened new MRDB.WS positions and 0 closed out — a net gain of 24 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Linden Advisors, opening a new position worth an estimated $1.3M.

  • 24 institutional investors held MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share (MRDB.WS) as of Q4 2022, up from 0 in Q3 2022.
  • Funds reported $4.6M of MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share stock for Q4 2022.
  • 24 funds opened new MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share positions in Q4 2022 and 0 closed out, a net change of +24 holders.
  • The largest MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share buyer in Q4 2022 was Linden Advisors, an estimated $1.3M added.

Based on aggregated 13F filings for Q4 2022.